Damora Therapeutics, Inc. — SC 13G/A Filings
7 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Damora Therapeutics, Inc. (DMRA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Damora Therapeutics, Inc. has filed 7 SC 13G/A documents with the SEC since 2020. To view all SEC filings by Damora Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
4
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | SC 13G/A | 0001193125-24-253039 | Nov 7, 2024 | — |
| SC 13G/A | — | 0001995601-24-000004 | Aug 29, 2024 | — |
| SC 13G/A | — | 0000929638-22-000489 | Feb 14, 2022 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-22-020446 | Feb 11, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-034616 | Feb 10, 2022 | — |
| SC 13G/A | — | 0000929638-21-000378 | Feb 16, 2021 | — |
| SC 13G/A | SC 13G/A | 0001193125-21-041869 | Feb 12, 2021 | — |